Literature DB >> 18157678

Disseminated cryptococcosis in HIV-uninfected patients.

Y-M Chuang1, Y-C Ho, H-T Chang, C-J Yu, P-C Yang, P-R Hsueh.   

Abstract

Cryptococcus neoformans usually causes disease in patients with human immunodeficiency virus (HIV) infection. This descriptive study was based on a retrospective review of 33 HIV-uninfected patients with disseminated cryptococcosis from 1998 to 2005. An underlying condition associated with immunocompromise was documented in 30 patients (90.9%), including liver cirrhosis (36.4%), diabetes mellitus (33.3%) and autoimmune disease (27.3%). Disseminated cryptococcosis carried a high mortality rate in this series, reaching 63% overall, with a median survival of 21 days. All patients (12/12) with liver cirrhosis died within the first month after the diagnosis of cryptococcosis. Otherwise, high Acute Physiology and Chronic Health Evaluation II (APACHE II) score, female gender and smoking history were associated with worse one-month outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18157678     DOI: 10.1007/s10096-007-0430-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Association of fungal infection and increased mortality in liver transplant recipients.

Authors:  J M Rabkin; S L Oroloff; C L Corless; K G Benner; K D Flora; H R Rosen; A J Olyaei
Journal:  Am J Surg       Date:  2000-05       Impact factor: 2.565

2.  Nosocomial transmission of cryptococcosis.

Authors:  Cheng-Yi Wang; Huey-Dong Wu; Po-Ren Hsueh
Journal:  N Engl J Med       Date:  2005-03-24       Impact factor: 91.245

Review 3.  Cryptococcosis.

Authors:  Methee Chayakulkeeree; John R Perfect
Journal:  Infect Dis Clin North Am       Date:  2006-09       Impact factor: 5.982

4.  Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

Authors:  P G Pappas; J R Perfect; G A Cloud; R A Larsen; G A Pankey; D J Lancaster; H Henderson; C A Kauffman; D W Haas; M Saccente; R J Hamill; M S Holloway; R M Warren; W E Dismukes
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

5.  Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis.

Authors:  C C Hsu; C M Leevy
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

6.  Cryptococcosis in cirrhotic patients.

Authors:  Alex Vianey Callado França; Marcos Carneiro; Karina dal Sasso; Cacilda da Silva Souza; Ana Martinelli
Journal:  Mycoses       Date:  2005-01       Impact factor: 4.377

Review 7.  Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent.

Authors:  Alessandro Comarú Pasqualotto; Cecília Bittencourt Severo; Flávio de Mattos Oliveira; Luiz Carlos Severo
Journal:  Rev Iberoam Micol       Date:  2004-09       Impact factor: 1.044

8.  Cryptococcaemia: clinical features and prognostic factors.

Authors:  S-S Jean; C-T Fang; W-Y Shau; Y-C Chen; S-C Chang; P-R Hsueh; C-C Hung; K-T Luh
Journal:  QJM       Date:  2002-08

9.  T and B cell function in alcoholic liver disease.

Authors:  K T Nouri-Aria; G J Alexander; B C Portmann; J E Hegarty; A L Eddleston; R Williams
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

Review 10.  Cirrhosis: a risk factor for cryptococcal peritonitis.

Authors:  C L Mabee; S W Mabee; R B Kirkpatrick; S L Koletar
Journal:  Am J Gastroenterol       Date:  1995-11       Impact factor: 10.864

View more
  23 in total

1.  Uncommon mycosis in a patient with diabetes.

Authors:  Kuruswamy Thurai Prasad; Inderpaul Singh Sehgal; M R Shivaprakash; Sahajal Dhooria
Journal:  BMJ Case Rep       Date:  2016-02-25

Review 2.  Transmission and epidemiology of zoonotic protozoal diseases of companion animals.

Authors:  Kevin J Esch; Christine A Petersen
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

3.  Delayed diagnosis of cryptococcal meningoencephalitis due to negative cryptococcal antigen test.

Authors:  Bernhard Kessler; Frank Bally; Ekkehard Hewer; Parham Sendi
Journal:  BMJ Case Rep       Date:  2013-01-29

4.  Disseminated cryptococcosis, an unusual cause of gross proteinuria in an HIV-infected patient.

Authors:  Jay Shavadia; Shahin Sayed; Gunturu Revathi; Ahmed Sokwala; Mohamed Said Abdullah
Journal:  NDT Plus       Date:  2009-04

5.  Cryptococcus neoformans infection in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected patients at an inner-city tertiary care hospital in the Bronx.

Authors:  Hyun Ah Yoon; Uriel Felsen; Tao Wang; Liise-Anne Pirofski
Journal:  Med Mycol       Date:  2020-06-01       Impact factor: 4.076

6.  Cirrhosis, gastrointestinal bleed, and cryptococcal peritonitis.

Authors:  Amy E Barnett; Karen B Brust
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-02-11

7.  A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Authors:  Tran Th Chau; Nguyen H Mai; Nguyen H Phu; Ho D Nghia; Ly V Chuong; Dinh X Sinh; Van A Duong; Pham T Diep; James I Campbell; Stephen Baker; Tran T Hien; David G Lalloo; Jeremy J Farrar; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

8.  Cryptococcus neoformans meningoencephalitis in a patient with polyarteritis nodosa.

Authors:  Vladimír Buchta; Petr Prášil; Marcela Vejsová; Roman Mottl; Radka Kutová; Marcela Drahošová; Stanislav Plíšek
Journal:  Folia Microbiol (Praha)       Date:  2014-06-20       Impact factor: 2.099

9.  Disseminated cryptococcosis in an apparently immunocompetent patient presenting with primary intraventricular haemorrhage.

Authors:  Partha Pal; Sayantan Ray; Sisir Kumar Patra; Debabrata Mukherjee
Journal:  BMJ Case Rep       Date:  2015-10-22

10.  Disseminated cryptococcosis with meningitis, peritonitis, and cryptococcemia in a HIV-negative patient with cirrhosis: a case report.

Authors:  Baligh Ramzi Yehia; Michael Eberlein; Stephen D Sisson; David N Hager
Journal:  Cases J       Date:  2009-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.